ID: h-d69f2fdd
Hypothesis

CNTF-JAK/STAT3 Reprogramming of Trained Microglia to Neuroprotective State

Astrocyte-derived CNTF binds CNTFRα-GP130-LIFRβ receptor complex on microglia, activating JAK1/2 → STAT3 phosphorylation.
🧬 CNTFRα/GP130 → JAK1/JAK2 → p-STAT3(Y705)🩺 neuroinflammation🎯 Composite 55%💱 $0.56▼11.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 3 oppose
✓ All Quality Gates Passed

🧪 Overview

Astrocyte-derived CNTF binds CNTFRα-GP130-LIFRβ receptor complex on microglia, activating JAK1/2 → STAT3 phosphorylation. Nuclear STAT3 recruits HDAC3 and GLCCR2 corepressors to reset trained enhancers while inducing neuroprotective genes (ARG1, CD206, IL10). Context-dependent effects and speculative corepressor mechanism limit confidence.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Cytokine Receptor Engagement<br/>IL6R/GP130 Activation"]
    B["JAK1 Activation<br/>Kinase Domain Autophosphorylation"]
    C["STAT3 Phosphorylation<br/>SASP Transcriptional Program"]
    D["Microglial Pro-inflammatory State<br/>TNF and IL1B Release"]
    E["Synaptic Toxicity<br/>Excitatory Damage and Dendritic Loss"]
    F["JAK1 Inhibition<br/>STAT3 Cascade Disruption and Inflammation Resolution"]
    A --> B
    B --> C
    C --> D
    D --> E
    F -.->|"blocks"| C
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
CNTF modulates microglial activation in optic nerve injury
Supports
STAT3 activation in microglia suppresses neuroinflammation via Arg1 induction
Supports
Astrocyte CNTF release increases with reactive astrogliosis
Contradicts
STAT3 in microglia promotes pro-inflammatory cytokine production in EAE; context-dependent
Contradicts
CNTF effects demonstrated in optic nerve crush, not chronic neurodegeneration
Contradicts
Astrogliosis-associated CNTF release is consequence of neuroinflammation, not preventive mechanism
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CNTFRΑ

No curated PDB or AlphaFold mapping for CNTFRΑ yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CNTFRα →

No DepMap CRISPR Chronos data found for CNTFRα.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.7%
Volatility
Medium
0.0408
Events (7d)
3
Price History
▼11.5%

💾 Resource Usage

LLM Tokens
13,698
$0.0411
Total Cost
$0.0411

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF microglia are treated with CNTF for 4 hours, THEN ChIP-seq will reveal STAT3 binding co-enriched with HDAC3 and GLCCR2 at promoters of ARG1, CD206, and IL10 at trained enhancer regions, exceeding ICo-occupancy of STAT3, HDAC3, and GLCCR2 at ≥75% of upregulated neuroprotective gene promoters, with genomic colocalization confirmed by ChIP-seq peak overlap a— no observation —pending0.20
IF primary mouse microglia are treated with 50 ng/mL CNTF for 30 minutes, THEN phospho-STAT3(Y705) levels will increase by at least 2-fold relative to vehicle control as measured by Western blot withiSTAT3 phosphorylation (Y705) will increase ≥2-fold in microglia following CNTF treatment, coinciding with upregulated ARG1, CD206, and IL10 mRNA expression (≥1.— no observation —pending0.35
🔮 Falsifiable Predictions (2)
pendingconf 35%
IF primary mouse microglia are treated with 50 ng/mL CNTF for 30 minutes, THEN phospho-STAT3(Y705) levels will increase by at least 2-fold relative to vehicle control as measured by Western blot within 24 hours.
Predicted outcome: STAT3 phosphorylation (Y705) will increase ≥2-fold in microglia following CNTF treatment, coinciding with upregulated ARG1, CD206, and IL10 mRNA expre
Falsification: No significant change in p-STAT3(Y705) levels (<1.5-fold) or no induction of neuroprotective genes (ARG1, CD206, IL10) despite CNTF treatment would refute the receptor-complex signaling hypothesis.
pendingconf 20%
IF microglia are treated with CNTF for 4 hours, THEN ChIP-seq will reveal STAT3 binding co-enriched with HDAC3 and GLCCR2 at promoters of ARG1, CD206, and IL10 at trained enhancer regions, exceeding IgG background by ≥3-fold.
Predicted outcome: Co-occupancy of STAT3, HDAC3, and GLCCR2 at ≥75% of upregulated neuroprotective gene promoters, with genomic colocalization confirmed by ChIP-seq peak
Falsification: STAT3 binds target gene promoters but HDAC3 and/or GLCCR2 show no significant enrichment (≤1.5-fold over IgG) at those sites would falsify the corepressor recruitment mechanism, suggesting alternative
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.